Essay
Alexander Schubert explores whether biopharma's back-office infrastructure represents the next major AI opportunity.
Is the Boring Backbone of Biopharma the Next Big AI Opportunity?
Essay
Alexander Schubert writes about venom-derived compounds as a frontier area for scientific founders.
Into the venom mines
SEP 10, 2025